BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

BioVex 

34 Commerce Way

Woburn  Massachusetts  01801  U.S.A.
Phone: 781-933-1409 Fax: 781-933-6025


SEARCH JOBS


Industry
Biotechnology

Segment
Oncology





 Company News
Amgen (AMGN) Raises Presence in Massachusetts With BioVex Buy, Boosts Hiring 3/9/2011 8:19:18 AM    More...
Amgen (AMGN) Completes Acquisition of BioVex 3/7/2011 6:36:10 AM    More...
Amgen (AMGN) to Acquire BioVex, a Privately Held Biotechnology Company Headquartered in Woburn, Mass for up to $1 Billion 1/25/2011 6:40:41 AM    More...
BioVex to Present at 29th Annual JP Morgan Healthcare Conference 1/5/2011 9:16:31 AM    More...
BioVex Commences OncoVEXGM-CSF Phase 3 Trial in Head and Neck Cancer 12/10/2010 8:41:36 AM    More...
BioVex Announces Publication of Head and Neck Cancer Clinical Trial Results with OncoVEX GM-CSF in the Journal Clinical Cancer Research 8/2/2010 8:21:30 AM    More...
BioVex Appoints Ex Roche (RHHBY) Oncology Head, Kapil Dhingra, to the Board of Directors 7/22/2010 9:19:38 AM    More...
BioVex Appoints Steven Kelly as Chief Commercial Officer 7/1/2010 10:00:59 AM    More...
BioVex Initiates Phase 1 Clinical Trial with Its Genital Herpes Vaccine, ImmunoVEX(HSV2) 3/4/2010 9:11:01 AM    More...
BioVex Announces Broadened Inclusion Criteria in Phase 3 Melanoma Study; OncoVEX to be Evaluated in First Line Patients and Those Previously Treated 1/6/2010 9:21:44 AM    More...
12345

//-->